[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Formulation (Cream, Gel, Spray, Patch, and Others), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), and Distribution Channel (Pharmacies & Drug Stores, E-Commerce, and Retail & Grocery Stores): Global Opportunity Analysis and Industry Forecast,2027

July 2023 | 224 pages | ID: T1E44CD9E57AEN
IHR Insights

US$ 4,500.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The topical pain relief market refers to the market for products that are applied externally to alleviate pain and discomfort. These products typically come in the form of creams, gels, sprays, patches, or ointments and they are designed to provide localized relief for various types of pain, such as muscle aches, joint pain, arthritis, strains, and sprains. The topical pain relief market has experienced significant growth in recent years due to several factors. These include the increasing prevalence of chronic pain conditions, such as arthritis and back pain, the aging population, and the growing demand for non-invasive and drug-free pain management options. Additionally, the rise in sports-related injuries and the growing adoption of topical pain relief products among athletes have contributed to market expansion. Moreover, there has been a growing awareness and acceptance of topical pain relief products among healthcare professionals and consumers which further leads to market growth. As more research is conducted and evidence supporting their effectiveness accumulates, healthcare providers are more likely to recommend these products to their patients. Additionally, consumers are increasingly open to exploring alternative pain relief options, driving the demand for topical solutions. However, the factors such as irritated skin, pungent smell of the medication may hamper the market growth. Topical Pain Relief Market is likely to grow at a rate of 6.1% CAGR by 2027.

Topical Pain Relief marketby Therapeutic

Non-opioids
Opioids

Topical Pain Relief market by Formulation

Cream
Gel
Spray
Patch

Topical Pain Relief market by Distribution Channel

Pharmacies & drug stores
E-Commerce
Retail & grocery stores

Topical Pain Relief Market by Geography

North America
Europe
Asia Pacific
Rest of the World

Based on therapeutic, the market is bifurcated into Non-opioids and Opioids. The Non-opioids segment expected to have the highest share in the market. This is due to its preferable usage over the opioid drugs for treatment of mild to moderate pain. Moreover, owing to minimum side effects as compared to opioids and no substance abuse, non-opioids are the preferred choice for the treatment of pain.

On the bases of formulation, the market has been divided into Cream, Gel, Spray and Patch. Cream-based formulation segment has held a maximum share in the market. The maximum share is due to increased availability of these products with a high success rate and minimum side effects.

Key players in the topical pain relief market include pharmaceutical companies, consumer healthcare companies, and specialized manufacturers. Some of the well-known brands in this market include Bengay, Icy Hot, Voltaren, Biofreeze, and Salonpas, among others. These companies offer a wide range of products with different active ingredients and formulations to target specific types of pain.

In terms of distribution channel, topical pain relief products are available over-the-counter (OTC) in pharmacies, drugstores, supermarkets, and online retail platforms. Some products may also require a prescription and are sold through healthcare providers and pharmacies.

The topical pain relief market is highly competitive, and companies are continuously innovating to develop new formulations and improve the effectiveness of their products. Some of the advancements in this market include the incorporation of natural ingredients, the use of transdermal drug delivery systems, and the development of products with longer-lasting effects.

It's important to note that as an AI, my knowledge cutoff is in September 2021. Therefore, there may have been further developments or changes in the topical pain relief market since then...

The major leading companies of the topical pain relief market are Advacare Pharma, Glaxosmithkline Plc (Gsk), Johnson & Johnson, Nestlй S.A, Novartis Ag, Pfizer Inc, Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industries Ltd, and Topical Biomedics, Inc.

It's worth noting that market trends and dynamics can change over time. For the most up-to-date information on the current state of the market, it is advisable to refer to recent market research reports, industry publications, and engage with experts in the pharmaceutical sector. An exclusive analysis of all key geographical regions is included in the report which determines the potential opportunities in these regions.
Detailed information about the attributes which are generating growth in the topical pain relief market in the forecast period.
An exact estimation of the topical pain relief market share and its contribution to the parent market is provided in the report.
Further profiles of leading competitors and their dynamic strategies are also covered in thestudy.
1. EXECUTIVE SUMMARY

2. INDUSTRY OUTLOOK

2.1. Industry Overview
2.2. Industry Trends

3. MARKET SNAPSHOT

3.1. Market Definition
3.2. Market Outlook
  3.2.1. Porter Five Forces
3.3. Related Markets

4. MARKET CHARACTERISTICS

4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. DRO - Impact Analysis

5. THERAPEUTIC: MARKET SIZE & ANALYSIS

5.1. Overview
5.2. Non-opioids
5.3. Opioids

6. FORMULATION: MARKET SIZE & ANALYSIS

6.1. Overview
6.2. Cream
6.3. Gel
6.4. Spray
6.5. Patch

7. DISTRIBUTION CHANNEL: MARKET SIZE & ANALYSIS

7.1. Overview
7.2. Pharmacies & drug stores
7.3. E-Commerce
7.4. Retail & grocery stores

8. GEOGRAPHY: MARKET SIZE & ANALYSIS

8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World

9. COMPETITIVE LANDSCAPE

9.1. Competitor Comparison Analysis
9.2. Market Developments
  9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
  9.2.2. Product Launches and execution

10. VENDOR PROFILES

10.1. Advacare Pharma
  10.1.1. Overview
  10.1.2. Financial Overview
  10.1.3. Product Offerings
  10.1.4. Developments
  10.1.5. Business Strategy
10.2. Glaxosmithkline Plc (Gsk)
  10.2.1. Overview
  10.2.2. Financial Overview
  10.2.3. Product Offerings
  10.2.4. Developments
  10.2.5. Business Strategy
10.3. Johnson & Johnson
  10.3.1. Overview
  10.3.2. Financial Overview
  10.3.3. Product Offerings
  10.3.4. Developments
  10.3.5. Business Strategy
10.4. Nestlй S.A
  10.4.1. Overview
  10.4.2. Financial Overview
  10.4.3. Product Offerings
  10.4.4. Developments
  10.4.5. Business Strategy
10.5. Novartis Ag
  10.5.1. Overview
  10.5.2. Financial Overview
  10.5.3. Product Offerings
  10.5.4. Developments
  10.5.5. Business Strategy
10.6. Pfizer Inc
  10.6.1. Overview
  10.6.2. Financial Overview
  10.6.3. Product Offerings
  10.6.4. Developments
  10.6.5. Business Strategy
10.7. Reckitt Benckiser Group Plc
  10.7.1. Overview
  10.7.2. Financial Overview
  10.7.3. Product Offerings
  10.7.4. Developments
  10.7.5. Business Strategy
10.8. Sanofi
  10.8.1. Overview
  10.8.2. Financial Overview
  10.8.3. Product Offerings
  10.8.4. Developments
  10.8.5. Business Strategy
10.9. Sun Pharmaceutical Industries Ltd
  10.9.1. Overview
  10.9.2. Financial Overview
  10.9.3. Product Offerings
  10.9.4. Developments
  10.9.5. Business Strategy
10.10. Topical Biomedics, Inc
  10.10.1. Overview
  10.10.2. Financial Overview
  10.10.3. Product Offerings
  10.10.4. Developments
  10.10.5. Business Strategy

11. ANALYST OPINION

12. ANNEXURE

12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
  12.3.1. Data Collation and In-house Estimation
  12.3.2. Market Triangulation
  12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations


LIST OF TABLES

TABLE 1. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR NON-OPIOIDS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR OPIOIDS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR CREAM, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR GEL, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR SPRAY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR PATCH, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR PHARMACIES & DRUG STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR E-COMMERCE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL TOPICAL PAIN RELIEF MARKET VALUE FOR RETAIL & GROCERY STORES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 14. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 15. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 17. U.S TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 18. U.S TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 19. U.S TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 20. CANADA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 21. CANADA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 22. CANADA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 23. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 24. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 25. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 26. EUROPE TOPICAL PAIN RELIEF MARKET VALUE, DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 27. GERMANY TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 28. GERMANY TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 29. GERMANY TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 30. U.K TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 31. U.K TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 32. U.K TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 33. FRANCE TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 34. FRANCE TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 35. FRANCE TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 36. ITALY TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 37. ITALY TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 38. ITALY TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 39. SPAIN TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 40. SPAIN TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 41. SPAIN TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 42. ROE TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 43. ROE TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 44. ROE TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 45. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 46. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 47. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 48. ASIA PACIFC TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 49. CHINA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 50. CHINA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 51. CHINA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 52. INDIA TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 53. INDIA TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 54. INDIA TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 55. JAPAN TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 56. JAPAN TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 57. JAPAN TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 58. REST OF APAC TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 59. REST OF APAC TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 60. REST OF APAC TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 61. REST OF WORLD TOPICAL PAIN RELIEF MARKET VALUE, BY THERAPEUTIC, 2021-2027 (USD BILLION)
TABLE 62. REST OF WORLD TOPICAL PAIN RELIEF MARKET VALUE, BY FORMULATION, 2021-2027 (USD BILLION)
TABLE 63. REST OF WORLD TOPICAL PAIN RELIEF MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)
TABLE 64. ADVACARE PHARMA: FINANCIALS
TABLE 65. ADVACARE PHARMA: PRODUCTS & SERVICES
TABLE 66. ADVACARE PHARMA: RECENT DEVELOPMENTS
TABLE 67. GLAXOSMITHKLINE PLC (GSK): FINANCIALS
TABLE 68. GLAXOSMITHKLINE PLC (GSK): PRODUCTS & SERVICES
TABLE 69. GLAXOSMITHKLINE PLC (GSK): RECENT DEVELOPMENTS
TABLE 70. JOHNSON & JOHNSON: FINANCIALS
TABLE 71. JOHNSON & JOHNSON: PRODUCTS & SERVICES
TABLE 72. JOHNSON & JOHNSON: RECENT DEVELOPMENTS
TABLE 73. NESTLЙ S.A: FINANCIALS
TABLE 74. NESTLЙ S.A: PRODUCTS & SERVICES
TABLE 75. NESTLЙ S.A: RECENT DEVELOPMENTS
TABLE 76. NOVARTIS AG: FINANCIALS
TABLE 77. NOVARTIS AG: PRODUCTS & SERVICES
TABLE 78. NOVARTIS AG: RECENT DEVELOPMENTS
TABLE 79. PFIZER INC: FINANCIALS
TABLE 80. PFIZER INC: PRODUCTS & SERVICES
TABLE 81. PFIZER INC: RECENT DEVELOPMENTS
TABLE 82. RECKITT BENCKISER GROUP PLC: FINANCIALS
TABLE 83. RECKITT BENCKISER GROUP PLC: PRODUCTS & SERVICES
TABLE 84. RECKITT BENCKISER GROUP PLC: RECENT DEVELOPMENTS
TABLE 85. SANOFI: FINANCIALS
TABLE 86. SANOFI: PRODUCTS & SERVICES
TABLE 87. SANOFI: RECENT DEVELOPMENTS
TABLE 88. SUN PHARMACEUTICAL INDUSTRIES LTD: FINANCIALS
TABLE 89. SUN PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS & SERVICES
TABLE 90. SUN PHARMACEUTICAL INDUSTRIES LTD: RECENT DEVELOPMENTS
TABLE 91. TOPICAL BIOMEDICS, INC: FINANCIALS
TABLE 92. TOPICAL BIOMEDICS, INC: PRODUCTS & SERVICES
TABLE 93. TOPICAL BIOMEDICS, INC: RECENT DEVELOPMENTS


More Publications